35 results found.

Kidney Transplantation, or GI Symptoms Severity Clinical Trial

Novartis - Recruiting 18 years or older.
- Open, Multi-centre, Non-interventional, Observational Study to Characterize the Impact That GI Complaints Have on Patient-reported Outcomes in Patients Who Have Had a Renal Transplant. Patients Will be Evaluated at Visit 1 and Then Again After 4 (+2) Weeks (Visit 2).

Kidney Transplantation Recipients Clinical Trial

Asan Medical Center - Recruiting 16 years to 90 years.
- Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients (ACE-KT).

Kidney Transplantation Clinical Trial

Asan Medical Center - Recruiting 16 years or older.
- Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT).

Kidney Transplant Clinical Trial using Ropivacaine 500mg/100ml Naropeine; 0.9% sodium chloride BAXTER

Centre Hospitalier Universitaire Dijon - Recruiting 18 years or older.
- Transversus Abdominis Plane Block During Kidney Transplant Surgery: Prospective Controlled Randomized Double-blind Trial Comparing Ropivacaine 0.2% With Placebo..
Ropivacaine 500mg/100ml Naropeine; 0.9% sodium chloride BAXTER

Cytomegalovirus Infections Clinical Trial using RG7667; Placebo

Genentech - Recruiting 18 years or older.
- A Phase II Randomized, Double-Blind, Placebo-Controlled Trial of RG7667 for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients.
RG7667; Placebo

Kidney Transplantation Clinical Trial using Belatacept

East Carolina University - Recruiting 18 years to 75 years.
- An Exploratory, Open-label, Single Center Study to Assess the Efficacy of NULOJIX (Belatacept) in Reducing Donor Specific HLA Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients.
Belatacept

Liver Disease, or Renal Disease Clinical Trial

Baylor Research Institute - Recruiting 18 years or older.
- Quantitative Evaluation of Liver and Kidney Disease With Liver and Kidney Elastography Measurements in Liver Transplant Recipients Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine.

Renal Transplant Candidate for Right Kidney, or Renal Transplant Clinical Trial

University of Aarhus - Recruiting 18 years or older.
- Angiographic CT of Renal Transplantation Candidate - Study.

Kidney Disease, Kidney Transplantation, or Kidney Failure, Chroni Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes.

Renal Cell Carcinoma, Graft-Versus-Host Disease, or Engraftment S Clinical Trial using Pentostatin; Sirolimus; Cyclophosphamide; Allogeneic Hematopoietic Stem Cell Transplant; Th2 Cell Transplantation; Th2 Cells in Allogeneic HSCT

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 75 years.
- Low Intensity Allogeneic Hematopoietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma Using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells.
Pentostatin; Sirolimus; Cyclophosphamide; Allogeneic Hematopoietic Stem Cell Transplant; Th2 Cell Transplantation; Th2 Cells in Allogeneic HSCT

Kidney Transplant Clinical Trial using Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal; MMF/Tacrolimus/Prednisone

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years or older.
- Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation.
Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal; MMF/Tacrolimus/Prednisone

Kidney Transplantation Clinical Trial using Cyclosporine; CP-690,550

Pfizer - Recruiting 18 years to 70 years.
- A Phase 2, Multicenter, Open-Label, Active Comparator-Controlled, Extension Trial To Evaluate The Long-Term Safety And Efficacy Of CP-690,550 In Renal Allograft Recipients.
Cyclosporine; CP-690,550

Kidney Transplant Recipient Clinical Trial using 64-slice Multidetector coronary CT angiography

Yonsei University - Recruiting 40 years or older.
- .
64-slice Multidetector coronary CT angiography

Unspecified Complications of Kidney Transplant, or Disorder Relat Clinical Trial using Workbook

Northwestern University - Recruiting 18 years to 85 years.
- Evaluation of Sun Protection Education for Kidney Transplant Recipients.
Workbook

End-stage Kidney Disease Clinical Trial using Inform Me: web-based education tool

Northwestern University - Recruiting 21 years or older.
- Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors.
Inform Me: web-based education tool

Kidney Transplantation Clinical Trial using Tacrolimus; CP-690,550

Pfizer - Recruiting 18 years to 70 years.
- A Multicenter, Phase 2, Open-Label, Controlled, Extension Study For Stage 1 Subjects Of Study A3921009 To Evaluate The Long-Term Safety And Efficacy Of CP-690,550 Versus Tacrolimus, When Co-Administered With Mycophenolate Mofetil In Renal Allograft Recipients.
Tacrolimus; CP-690,550

Kidney Transplantation, Renal Transplantation Clinical Trial using RAD001; Tacrolimus; Cyclosporin A; Enteric Coated Mycophenolate Sodium (EC-MPS) or Mycophenolate Mofetil (MMF); Corticosteroids

Novartis - Recruiting 18 years or older.
- 12 Month, Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Certicanr Based Regimen Either in Combination With Cyclosporin A or Tacrolimus.
RAD001; Tacrolimus; Cyclosporin A; Enteric Coated Mycophenolate Sodium (EC-MPS) or Mycophenolate Mofetil (MMF); Corticosteroids

Kidney Transplantation Clinical Trial using Everolimus; Sirolimus

University of Colorado, Denver - Recruiting 18 years to 70 years.
- Differentiating Sirolimus and Everolimus in Combination With Calcineurin Inhibitors in Long-term Maintenance of Kidney Transplant Patients - The Effects on Vascular Endothelial and Kidney Function. The DESIRE Study..
Everolimus; Sirolimus

Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymph Clinical Trial using Haploidentical Bone Marrow/Kidney

Massachusetts General Hospital - Recruiting 18 years to 70 years.
- Combined Haploidentical Reduced Intensity Bone Marrow and Kidney Transplantation for Patients With Chronic Kidney Disease and Advanced Hematological Disorders.
Haploidentical Bone Marrow/Kidney

Transplant; Failure, Kidney Clinical Trial

University of Miami - Recruiting 7 years to 75 years.
- Desensitization Protocol for Deceased Donor List.

Kidney Transplantation Clinical Trial using Hematopoietic Stem Cell Transplant/novel platform technology

University of Louisville - Recruiting 18 years to 65 years.
- Delayed Tolerance in Recipients of Living Kidney Allografts by Donor Stem Cell Infusion.
Hematopoietic Stem Cell Transplant/novel platform technology

Kidney Transplant Recipients, or Liver Transplant Recipients Clinical Trial using Prograf brand and tacrolimus generic

University of Cincinnati - Recruiting 18 years or older.
- Pharmacokinetic Studies of Tacrolimus in Transplant Patients.
Prograf brand and tacrolimus generic

Kidney Transplantation Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- Prospective, Open-label, Non-interventional Study for the Follow-up of Renal Function in de Novo Kidney Transplant Patients Treated With Immunosuppressive Therapy Containing CellCept in Routine Clinical Practice (ORANGE Study).

Prevention of New Onset Diabetes Among Kidney Transplant Patients Clinical Trial using Insulin treatment for hyperglycemia

University of Michigan - Recruiting 18 years or older.
- A Clinical Trial to Prevent New Onset Diabetes After Transplantation.
Insulin treatment for hyperglycemia

Resistant Hypertension in Kidney Transplant Patients Clinical Trial using Chlorthalidone

Virginia Commonwealth University - Recruiting 18 years or older.
- Chlorthalidone for the Management of Resistant Hypertension in Kidney Transplant Patients.
Chlorthalidone

End Stage Renal Disease Clinical Trial using Kidney Transplant

University of Kansas - Recruiting 30 years to 70 years.
- Cognitive Impairment and Imaging Correlates in End Stage Renal Disease.
Kidney Transplant

Kidney Transplantation Clinical Trial using Antithymocyte globulin (ATG); Fludarabine; Low dose Pre-transplant cyclophosphamide; Total Body Irradiation; Acetaminophen; Diphenhydramine; Methylprednisolone; Bone Marrow; MESNA; Mycophenolate mofetil (MMF); Prednisone; Filgrastim; High dose post-transplant cyclophosphamide

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 65 years.
- Bone Marrow Transplantation and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance (ITN054ST).
Antithymocyte globulin (ATG); Fludarabine; Low dose Pre-transplant cyclophosphamide; Total Body Irradiation; Acetaminophen; Diphenhydramine; Methylprednisolone; Bone Marrow; MESNA; Mycophenolate mofetil (MMF); Prednisone; Filgrastim; High dose post-transplant cyclophosphamide

Hyponatremia Clinical Trial using Conivaptan hydrochloride; Placebo

Astellas Pharma Inc - Recruiting 2 years to 17 years.
- A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center, Dose-Titration Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisolr) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia.
Conivaptan hydrochloride; Placebo

Kidney Transplant Clinical Trial using Belatacept; Tacrolimus; CsA

Bristol-Myers Squibb - Recruiting 6 years to 17 years.
- A Phase 2 Multi-Center, Randomized Conversion Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belatacept Administered to Pediatric Subjects With a Stable Renal Transplant.
Belatacept; Tacrolimus; CsA

Renal Transplant Candidate for Right Kidney Clinical Trial using Cholecalciferol 100 000 UI; Cholecalciferol 12 000 UI

Assistance Publique - H“pitaux de Paris - Recruiting 18 years to 75 years.
- Prospective Double Blind Multicentre Randomized Trial of Vitamine D Estimating the Profit of a Treatment by Vitamin D3 at the Dose of 100000 UI by Comparison With a Treatment in the Dose of 12 000 UI at Renal Transplanted Patients.
Cholecalciferol 100 000 UI; Cholecalciferol 12 000 UI

Kidney Transplantation, or Liver Transplantation Clinical Trial using Prevenar13; Pneumovax

Helsinki University Central Hospital - Recruiting 18 years to 70 years.
- Immunogenicity of Repeated Dose 13-valent Pneumococcal Conjugate Vaccine Compared to the Existing Recommended Protocol of Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients.
Prevenar13; Pneumovax

Kidney Transplant Clinical Trial using Zostavax (Live attenuated herpes zoster vaccine); Placebo vaccine

University of Alberta - Recruiting 18 years to 65 years.
- Safety and Immunogenicity of Live Attenuated Herpes Zoster Vaccine in Patients Undergoing Living Donor Kidney Transplantations.
Zostavax (Live attenuated herpes zoster vaccine); Placebo vaccine

Reduction in Sequelae Related to Calcineurin Inhibitors, Chimeric Clinical Trial using basiliximab

Drexel University - Recruiting 18 years to 75 years.
- One-year Exploratory Study to Evaluate the Safety of Partial Replacement of CNI With Chronic Administration of Simulect in de Novo Normal-risk Kidney Transplant Recipients Treated With MPA.
basiliximab

Cervical Cancer, Hpv, or Warts Clinical Trial using Quadrivalent HPV for types 6, 11, 16 and 18

Medstar Research Institute - Recruiting 9 years to 17 years.
- Immunogenicity Of A Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, And 18) L1 Virus-Like Particle Vaccine In Male And Female Adolescent Transplant Recipients..
Quadrivalent HPV for types 6, 11, 16 and 18

Kidney Cancer Clinical Trial using therapeutic allogeneic lymphocytes; cyclophosphamide; cyclosporine; fludarabine phosphate; allogeneic bone marrow transplantation; peripheral blood stem cell transplantation

National Cancer Institute (NCI) - Recruiting 18 years to 65 years.
- Phase II Trial in Intrafamilial Allogeneic Cell Transplant in Patients With Metastatic Kidney Cancer.
therapeutic allogeneic lymphocytes; cyclophosphamide; cyclosporine; fludarabine phosphate; allogeneic bone marrow transplantation; peripheral blood stem cell transplantation